Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NSD2 | O96028 | 1/20 | 0.67 |
| ▸ | G6PD | P11413 | 1/20 | 0.67 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.67 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.67 |
| ▸ | MGLL | Q99685 | 8/20 | 0.64 |
| ▸ | FAAH | O00519 | 4/20 | 0.64 |
| ▸ | DDAH1 | O94760 | 1/20 | 0.61 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.58 |
| ▸ | ALDH1A1 | P00352 | 5/20 | 0.58 |
| ▸ | HSP90AA1 | P07900 | 3/20 | 0.58 |
| ▸ | PKM | P14618 | 1/20 | 0.58 |
| ▸ | HTT | P42858 | 1/20 | 0.58 |
| ▸ | ATM | Q13315 | 1/20 | 0.58 |
| ▸ | KMT2A | Q03164 | 6/20 | 0.56 |
| ▸ | MEN1 | O00255 | 5/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.54 |
| ▸ | GAA | P10253 | 2/20 | 0.54 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.54 |
| ▸ | HPGD | P15428 | 2/20 | 0.54 |
| ▸ | MAPT | P10636 | 2/20 | 0.54 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL32670837 | 1.00 | NSD2 (0.67) | NSD2G6PDKEAP1NFE2L2MGLL | |
| Hydrochloric Acid SCHEMBL4956408 | 0.98 | NSD2 (0.65) | NSD2G6PDKEAP1NFE2L2MGLL | |
| Hydrazine SCHEMBL16912716 | 0.96 | NSD2 (0.62) | NSD2G6PDKEAP1NFE2L2MGLL | |
| Alcohol SCHEMBL29133134 | 0.92 | NSD2 (0.57) | NSD2G6PDKEAP1NFE2L2MGLL | |
| SCHEMBL8838907 | 0.92 | NSD2 (0.57) | NSD2G6PDKEAP1NFE2L2MGLL | |
| SCHEMBL1548309 | 0.88 | ALDH1A1 (0.54) | NSD2G6PDKEAP1NFE2L2MGLL | |
| SCHEMBL8530013 | 0.87 | MGLL (0.67) | NSD2G6PDKEAP1NFE2L2MGLL | |
| SCHEMBL7799644 | 0.86 | MGLL (0.60) | NSD2G6PDKEAP1NFE2L2MGLL | |
| SCHEMBL10515423 | 0.85 | PARP1 (0.65) | NSD2G6PDKEAP1NFE2L2MGLL | |
| SCHEMBL29510746 | 0.85 | PARP1 (0.65) | NSD2G6PDKEAP1NFE2L2MGLL |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 603 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2025091021-A1 | POLYMERIZED ALBUMIN AND METHODS OF MAKING AND USING THEREOF | OHIO STATE INNOVATION FOUNDATION (US) | 2025-05-01 | — | — | WO | claimed |
| WO-2025091017-A1 | SYNTHETIC WHOLE BLOOD SUBSTITUTES | OHIO STATE INNOVATION FOUNDATION (US) | 2025-05-01 | — | — | WO | claimed |
| EP-4251210-B1 | MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ANBITION S R L (IT) | 2025-03-19 | — | — | EP | claimed |
| EP-4251211-B1 | USE OF MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXIC DRUGS | ANBITION S R L (IT) | 2025-02-26 | — | — | EP | claimed |
| US-20240294609-A1 | STABILIZED HEMOGLOBIN COMPOSITIONS AND PHARMACEUTICAL FORMULATIONS THEREOF | GOLD BLAZE, LTD. (SG) | 2024-09-05 | — | — | US | claimed |
| US-20240000967-A1 | USE OF MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ANBITION S.R.L. (IT) | 2024-01-04 | — | — | US | claimed |
| CN-117304811-A | High-functionality vegetable oil-based UV (ultraviolet) light-cured resin as well as preparation method and application thereof | 佛山科学技术学院 | 2023-12-29 | — | — | CN | claimed |
| US-20230414772-A1 | MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ANBITION S.R.L. (IT) | 2023-12-28 | — | — | US | claimed |
| CN-117165366-A | Universal UV light-cured modified vegetable oil resin and synthetic method and application thereof | 佛山科学技术学院 | 2023-12-05 | — | — | CN | claimed |
| CN-117042807-A | Multispecific human albumin nanoparticles modified with antibody fragments and loaded with cytotoxic drugs | 安必圣有限责任公司 | 2023-11-10 | — | — | CN | claimed |
| WO-2007083984-A1 | CONJUGATE COMPRISING PHARMACEUTICAL ACTIVE COMPOUND COVALENTLY BOUND TO MUCOADHESIVE POLYMER AND TRANSMUCOSAL DELIVERY METHOD OF PHARMACEUTICAL ACTIVE COMPOUND USING THE SAME | GWANGJU INSTITUTE OF SCIENCE AND TECHNOLOGY (KR) | 2007-07-26 | — | — | WO | claimed |
| US-5466357-A | THERMOPLASTIC MATRIX PREPREG COMPOSITE PRODUCT | THE UNIVERSITY OF CONNECTICUT (US) | 1995-11-14 | — | — | US | claimed |
| US-5232560-A | Polymerizing at least one carboxy group containing monomer from aqueous solution onto electrically conductive filler material; thermally stable thermoplastic coatings; prepregs | BELL JAMES P (US) | 1993-08-03 | — | — | US | claimed |
| EP-0336856-B1 | WITH MALEIMIDE GROUPS FUNCTIONALIZED AROMATIC POLYAMIDEIMIDES, PROCESS FOR THEIR PREPARATION AND THEIR USE FOR PREPARING CROSS-LINKED POLYMERS | CIBA-GEIGY AG (CH) | 1993-03-03 | — | — | EP | claimed |
| EP-0526587-A1 | MODIFICATION OF POLYMER SURFACES BY TREATMENT WITH Ce(IV) SALTS AND ELECTROMAGNETIC RADIATION | NOVO NORDISK A/S (DK) | 1993-02-10 | — | — | EP | claimed |
| WO-1991016377-A1 | MODIFICATION OF POLYMER SURFACES BY TREATMENT WITH Ce(IV) SALTS AND ELECTROMAGNETIC RADIATION | NOVO NORDISK A/S (DK) | 1991-10-31 | — | — | WO | claimed |
| EP-0198309-B1 | METHOD FOR IMPROVING RUBBERS | NIPPON ZEON CO., LTD. (JP) | 1990-10-24 | — | — | EP | claimed |
| US-4927900-A | Aromatic polyamidoimides having maleimido end groups | RHONE-POULENC CHIMIE (FR) | 1990-05-22 | — | — | US | claimed |
| US-4704427-A | MODIFICATION WITH LEWIS ACID, CARBOXYLATION | NIPPON ZEON CO., LTD. (JP) | 1987-11-03 | — | — | US | claimed |
| EP-0227351-A2 | Immobilized C-peptide antibody, and the preparation and use thereof | SHIONOGI & CO., LTD. (JP) | 1987-07-01 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230414772-A1 | MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ALB, ASNS, ENPEP | NSD2 2675/4885G6PD 3594/4885KEAP1 3650/4885 |
| US-20240000967-A1 | USE OF MULTI-SPECIFIC HUMAN ALBUMIN NANOPARTICLES DECORATED WITH ANTIBODY FRAGMENTS AND LOADED WITH CYTOTOXICS | ALB, CD63, ENPEP | NSD2 4036/4885G6PD 2334/4885KEAP1 4608/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.